GlassScriptPhysician profile
Stanley C Graves
NPI 1992721914
$3,882.25
in general payments reported to CMS, 2019-2025
14 companies · $359 in 2025
The $359 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,830 · 2020: $178 · 2021: $310 · 2022: $300 · 2023: $707 · 2024: $199 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,264.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $1,658.45 | 2019-2020 | |
| Smith+Nephew, INC. | $1,134.59 | 2019-2024 | Panta 2, Evos, Maverick |
| Stryker Corporation | $360.33 | 2019-2025 | Inbone, Salvation |
| Sanara Medtech INC. | $200.98 | 2025 | Celleraterx |
| Zimmer Biomet Holdings, INC. | $125.00 | 2023 | Znn |
| Bioventus LLC | $86.73 | 2023-2025 | Exogen Ultrasound Bone Healing System, Xcell, Exogen Ultrasound Bone Healing System |
| Impactortho, INC. | $79.55 | 2024-2025 | |
| Treace Medical Concepts, INC. | $58.60 | 2023 | |
| Globus Medical, INC. | $43.03 | 2025 | Precice® Intramedullary Limb Lengthening System |
| Depuy Synthes Sales INC. | $38.81 | 2020 | |
| Medline Industries LP | $36.39 | 2022 | |
| Orthofix Medical, INC. | $28.94 | 2020-2024 | Physio-Stim |
| Abbvie INC. | $16.98 | 2023 | |
| Integra Lifesciences Corporation | $13.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Graves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.